Comprehensive historical analysis of global market for Isocitrate Dehydrogenase (IDH) Inhibitors has thoroughly analyzed in this report. It offers data and insights from 2019-2022, and provides extensive market forecasts from 2023-2032 by region/country and subsectors. It covers the price, sales volume, revenue, historical growth, gross margin, and future outlooks for the Isocitrate Dehydrogenase (IDH) Inhibitors market.
The Global Isocitrate Dehydrogenase (IDH) Inhibitors market is expected to grow USD 1.6 billion in 2021 and will reach USD 38.90 billion by 2030, at a CAGR 42.55% during the forecast period 2022-2030.
The report includes growth prospects in the Global Isocitrate Dehydrogenase (IDH) Inhibitors Market by type, application, sub segement and region and QMI has compiled a comprehensive detailed research report to offer insights. The report details consumption in the Healthcare and other sectors. Regional coverage spans North America, Europe, and rest of the world including Asia Pacific.
Leading players of Isocitrate Dehydrogenase (IDH) Inhibitors including:
List of Key Companies
- Bayer
- Agios Pharma
- Celgene
- Pfizer, Inc.
- Philogen S.p.A
- Ohm Oncology
- Tragara/Adastra
- Aslan Pharmaceuticals
- Daiichi Sankyo
- Sun Pharmaceutical Industries Ltd.
Request To Download Free Sample copy of the report @ https://www.sphericalinsights.com/request-sample/1634
Market split by Segement, can be divided into:
By Type
- IDH1 Mutant Medullary Malignant Tumor
- IDH2 Mutant Medullary Malignant Tumor
- Others
By Application
- FLT3 Inhibitor
- DH Inhibitor
- Hedgehog Pathway Inhibitor
- Others
Market segment by Region/Country including:
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- Uk
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia Pacific
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East Africa
- UAE
- Saudi Arabia
- Qatar
- South Africa
- Rest of Middle East Africa
Check discount for this report: https://www.sphericalinsights.com/request-discount/1634
On May 2020, Agios Pharmaceuticals reported updated data from the ongoing Phase 1 study evaluating single-agent vorasidenib in isocitrate dehydrogenase (IDH)-mutant advanced solid tumors, including glioma. Through that, American Society of Clinical Oncology, data from the non-enhancing glioma population were presented in an oral presentation, which is being held virtually.
Access full Report with Table of Content @ https://www.sphericalinsights.com/reports/isocitrate-dehydrogenase-idh-inhibitors-market
Whats covered in the report?
1. Overview of the Isocitrate Dehydrogenase (IDH) Inhibitors market.
2. The current and forecasted regional (North America, Europe, Asia-Pacific, Latin America, the Middle East and Africa) market size data for the Isocitrate Dehydrogenase (IDH) Inhibitors market, based on segement.
3. Isocitrate Dehydrogenase (IDH) Inhibitors Market trends.
4. Isocitrate Dehydrogenase (IDH) Inhibitors Market drivers.
5. Analysis of major company profiles.
Reasons to buy this Market Report:
1. Save time carrying out entry-level research by identifying the size, growth, and leading players in the emerging Isocitrate Dehydrogenase (IDH) Inhibitors market.
2. Use the SWOT analysis to determine the competitive intensity and therefore attractiveness of the emerging Isocitrate Dehydrogenase (IDH) Inhibitors Industry.
3. Leading company profiles reveal details of key Isocitrate Dehydrogenase (IDH) Inhibitors market players emerging five operations and financial performance.
4. Add weight to presentations and pitches by understanding the future growth prospects of the emerging Isocitrate Dehydrogenase (IDH) Inhibitors market with five year historical forecasts.
5. Compares data from North America, South America, Asia Pacific Europe and Middle East Africa, alongside individual chapters on each region.
6. Extensive information on factors that will amplify the growth of the Isocitrate Dehydrogenase (IDH) Inhibitors market over the upcoming seven years
7. Accurate estimation of the global Isocitrate Dehydrogenase (IDH) Inhibitors market size
8. Exact estimations of the upcoming trends and changes observed in the consumer behavior
9. Growth of the global Isocitrate Dehydrogenase (IDH) Inhibitors market across the North South America, EMEA, Asia Pacific, and Latin America
10. Information about Isocitrate Dehydrogenase (IDH) Inhibitors market growth potential
11. In-depth analysis of the industry’s competitive landscape and detailed information vis-a-vis on various vendors
12. Furnishing of detailed information on the factors that will restrain the growth of the Isocitrate Dehydrogenase (IDH) Inhibitors market
About the Spherical Insights
Spherical Insights is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.
which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements.
Contact Us:
Company Name: Spherical Insights
Email: sales@sphericalinsights.com
Phone: +1 303 800 4326 (US)
